RidgeWorth Capital Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 54.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 395,561 shares of the healthcare conglomerate’s stock after selling 472,029 shares during the period. RidgeWorth Capital Management LLC’s holdings in UnitedHealth Group were worth $64,875,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Groesbeck Investment Management Corp NJ raised its position in UnitedHealth Group by 4.0% in the first quarter. Groesbeck Investment Management Corp NJ now owns 34,342 shares of the healthcare conglomerate’s stock worth $5,632,000 after buying an additional 1,314 shares during the period. Great Lakes Advisors LLC raised its position in UnitedHealth Group by 152.5% in the first quarter. Great Lakes Advisors LLC now owns 65,491 shares of the healthcare conglomerate’s stock worth $10,741,000 after buying an additional 39,558 shares during the period. Penserra Capital Management LLC raised its position in UnitedHealth Group by 285.2% in the first quarter. Penserra Capital Management LLC now owns 2,400 shares of the healthcare conglomerate’s stock worth $393,000 after buying an additional 1,777 shares during the period. Coldstream Capital Management Inc. purchased a new position in UnitedHealth Group during the first quarter worth approximately $202,000. Finally, Bahl & Gaynor Inc. raised its position in UnitedHealth Group by 3.7% in the first quarter. Bahl & Gaynor Inc. now owns 209,461 shares of the healthcare conglomerate’s stock worth $34,354,000 after buying an additional 7,389 shares during the period. Hedge funds and other institutional investors own 86.26% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) opened at 194.88 on Friday. The company has a market cap of $191.96 billion, a P/E ratio of 23.41 and a beta of 0.64. The firm has a 50-day moving average of $186.80 and a 200 day moving average of $173.05. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period last year, the company earned $1.96 EPS. The firm’s revenue was up 7.7% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/06/unitedhealth-group-incorporated-nyseunh-position-reduced-by-ridgeworth-capital-management-llc.html.

A number of equities analysts have commented on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price target on the stock in a research report on Tuesday, August 1st. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 price target (up from $190.00) on shares of UnitedHealth Group in a research report on Saturday, July 22nd. Cantor Fitzgerald restated an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $212.00 price target on shares of UnitedHealth Group in a research report on Thursday, July 20th. One research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $200.24.

In other news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.